Business · 23/11/2007
FDA and Duke University Sign Memorandum of Understanding to Strengthen Human Subjects Protection in Clinical Trials
The FDA has announced a partnership with Duke University to modernize clinical trial processes, with the goal of improving the quality of human subjects protection in clinical trials.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →